REFERENCES
- Pittas AG, Chung M, Trikalinos T, . Vitamin D and cardiometabolic outcomes: a systematic review. Ann Intern Med 2010; 152:307–314.
- Vaidya A, Forman JP, Vitamin D. Hypertension: current evidence and future directions. Hypertension 2010; 56:774–779.
- Cardús A, Parisi E, Gallego C, Aldea M, Fernández E, Valdivielso JM. 1,25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway. Kidney Int 2006; 69:1377–1384.
- Ullah MI, Uwaifo GI, Nicholas WC, Koch CA. Does vitamin D deficiency cause hypertension? Current evidence from clinical studies and potential mechanisms. Int J Endocrinol 2010; 2010:579640.
- Ohkubo T, Hozawa A, Yamaguchi J, . Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens 2002; 20:2183–2189.
- Shimada K, Kawamoto A, Matsubayashi K, Nishinaga M, Kimura S, Ozawa T. Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J Hypertens 1992; 10:875–878.
- Fukuda M, Munemura M, Usami T, . Nocturnal blood pressure is elevated with natriuresis and proteinuria as renal function deteriorates in nephropathy. Kidney Int 2004; 65:621–625.
- Bischoff HA, Giovannucci E, Willett WC. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006; 84:18.
- Lang RM, Bierig M, Devereux RB, . Task Force on Chamber Quantification: recommendations for chamber quantification. Eur J Echocardiogr 2006; 2:79–108.
- Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55:613–618.
- DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004; 80:1689–1696.
- Judd SE, Tangpricha V. Vitamin D deficiency and risk for cardiovascular disease. Am J Med Sci 2009; 338:40–44.
- Resnick LM, Muller FB, Laragh JH. Calcium regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med 1986; 105:649–654.
- Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD. Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med 2008; 25:320–325.
- Martins D, Wolf M, Pan D, . Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2007; 167:1159–1165.
- Forman JP, Giovannucci E, Holmes MD, . Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007; 49:1063–1069.
- Wang TJ, Pencina MJ, Booth SL, . Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008; 117:503–511.
- Boldo A, Campbell P, Luthra P, White WB. Should the concentration of vitamin D be measured in all patients with hypertension? J Clin Hypertens (Greenwich) 2010; 12:149–152.
- Pfeifer M, Begerow B, Minne HW, Nachtigall D, Hansen C. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 2001; 86:1633–1637.
- Kanbay M, Isik B, Akcay A, . Relation between serum calcium, phosphate, parathyroid hormone and ‘nondipper’ circadian blood pressure variability profile in patients with normal renal function. Am J Nephrol 2007; 27:516–521.
- Seo HS, Kang TS, Park S, . Nondippers are associated with adverse cardiac remodeling and dysfunction. Int J Cardiol 2006; 112:171–177.